MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Depression profile in Mexican patients with Parkinson Disease: a cross-sectional study

    P. Reyes-Pérez, A. Medina-Rivera, A. Ruiz-Contreras, S. Alcauter-Solorzano, M. Rentería, A. Lazaro-Figueroa, Y. Matuk-Pérez, N. Gandarilla-Martínez, K. Salinas-Barboza, I. Estrada-Bellmann (Queretaro, Mexico)

    Objective: The present study aimed to provide a better understanding of depression manifestations in Mexican PD patients within the Mexican Parkinson’s Disease Research Network (MexPD),…
  • 2023 International Congress

    Cortical Control of Gait and Balance During Single and Dual Tasks in Huntington’s Disease: an fNIRS study

    J. O'Keefe, N. Purcell, S. Stuart, R. Vitorio, B. Ouyang, D. Hall (Chicago, USA)

    Objective: To examine the cortical control of gait and balance in HD under single-task (ST) and dual-task (DT) conditions compared to healthy controls using portable…
  • 2023 International Congress

    Investigation of superficial brain stimulation (SBS) in Parkinsonian rats as a non-invasive alternative treatment for patients with movement disorders

    G. Weistroffer, J. Blagg, M. Tashli, R. Hadimani, D. Kumbhare, M. Baron (Richmond, USA)

    Objective: To investigate repetitive transcranial magnetic stimulation (rTMS) in parkinsonian rats as a non-invasive, malleable superficial brain stimulation (SBS) alternative to DBS. Background: DBS is…
  • 2023 International Congress

    The effect of subthalamic therapeutic deep brain stimulation on pallidal and cortical activity in Parkinson’s disease

    F. Sarmento, J. Hernandez, T. de Araujo, J. Wong, D. Wang, P. Starr, C. de Hemptinne (Gainesville, USA)

    Objective: To evaluate the effect of subthalamic (STN) deep brain stimulation (DBS) on the globus pallidus (GP) and motor cortex Background: Progressive neuronal loss in…
  • 2023 International Congress

    The Prevalence of Primary Tauopathies in Ireland; a Clinically-Defined Study in the Province of Leinster: design and initial data.

    S. Lyons, R. Walsh, T. Lynch, S. O'Dowd (Dublin 24, Ireland)

    Objective: To investigate the epidemiology and phenomenology of PSP and CBS within the province of Leinster. Background: PSP and CBS are uncommon parkinsonian disorders. Studies…
  • 2023 International Congress

    The specific application of a motor rehabilitation package in correcting the psycho-emotional sphere in patients with Parkinson’s disease.

    N. Voloshyna, I. Bogdanova, I. Voloshyn-Haponov (Kharkiv, Ukraine)

    Objective: The study aimed to investigate the effectiveness of a motor rehabilitation programme for 48 patients with Parkinson's disease using the phenomenon of paradoxical kinesia…
  • 2023 International Congress

    Relevance of amyloid deposition for REM sleep behavior disorder in Parkinson’s disease

    J. Pineda-Pardo, M. López-Aguirre, G. Pagano, V. Gnoni, K. Ray Chaudhuri, G. Logroscino, D. Urso (Madrid, Spain)

    Objective: In this study, we aimed to investigate the relationship between regional [18F]florbetaben PET binding to amyloid-β (Aβ) and REM sleep behavior disorder (RBD) in…
  • 2023 International Congress

    CSF tau reflects long-term outcome of patients with idiopathic normal pressure hydrocephalus: a longitudinal retrospective study.

    J. Bissacco, C. Simonetta, D. Mascioli, N. Mercuri, T. Schirinzi (Roma, Italy)

    Objective: To predict long-term clinical outcome of iNPH patients through a panel of neurodegeneration-related CSF biomarkers. Background: Idiopathic normal pressure hydrocephalus (iNPH) is a neurodegenerative…
  • 2023 International Congress

    The effects of dopaminergic treatment on interhemispheric disinhibition and bradykinesia asymmetry in Parkinson’s disease

    M. de Riggi, G. Paparella, M. Bologna, D. Colella, A. Cannavacciuolo, A. de Biase, D. Birreci, D. Costa, A. Guerra, A. Berardelli (Rome, Italy)

    Objective: to investigate whether dopaminergic therapy modulates IHI and bradykinesia asymmetry in PD. Background: previous evidence demonstrated a reduced interhemispheric inhibition (IHI) in Parkinson’s disease…
  • 2023 International Congress

    Challenges in the measurement of brain iron deposition in Parkinson’s disease in non-academic research settings.

    B. Kashyap, K. Wyman-Chick, L. Hanson, S. Gustafson, S. Sherman, W. Frey, Ii, J. Johnson (St Paul, USA)

    Objective: Assess the feasibility of detecting brain iron deposition using quantitative susceptibility mapping (QSM) among patients with Parkinson’s disease (PD) in a community-based clinic setting.…
  • « Previous Page
  • 1
  • …
  • 67
  • 68
  • 69
  • 70
  • 71
  • …
  • 186
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley